Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Burke

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 14, 2001
US regulation of pharmaceutical outcomes researchL B Burke
American Pharmacy|September 1, 1979
Propoxyphene: an example of the need for increased pharmacist/patient interactionD L Kennedy, L B Burke
American Journal of Hospital Pharmacy|May 1, 1981
Need for uniform data elements in hospital drug use reviewM B Forbes, L B Burke, J K Jones
Clinical Pharmacology and Therapeutics|October 14, 2011
The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claimsS J Coons, S Kothari, B U Monz, et al.
Clinical Pharmacology and Therapeutics|June 27, 2008
The use of patient-reported outcome measures in the evaluation of medical products for regulatory approvalL B Burke, D L Kennedy, P H Miskala, et al.
Pharmacotherapy|July 1, 1997
Symptomatic cardiotoxicity associated with 5-fluorouracilC C Meyer, K A Calis, L B Burke, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practiceP S Jensen, V S Bhatara, B Vitiello, et al.
American Journal of Hospital Pharmacy|April 1, 1978
Low cost, manual drug use review of Medicaid recipients to screen prescriber and pharmacist performanceD E Knapp, D L Crosby, L B Burke, et al.
Radiologia|January 23, 2013
A comparison of a T1 weighted 3D gradient-echo sequence with three different parallel imaging reduction factors, breath hold and free breathing, using a 32 channel coil at 1.5 T. A preliminary studyV Herédia, B Dale, R Op de Campos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 14, 2001
US regulation of pharmaceutical outcomes researchL B Burke
American Pharmacy|September 1, 1979
Propoxyphene: an example of the need for increased pharmacist/patient interactionD L Kennedy, L B Burke
American Journal of Hospital Pharmacy|May 1, 1981
Need for uniform data elements in hospital drug use reviewM B Forbes, L B Burke, J K Jones
Clinical Pharmacology and Therapeutics|October 14, 2011
The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claimsS J Coons, S Kothari, B U Monz, et al.
Clinical Pharmacology and Therapeutics|June 27, 2008
The use of patient-reported outcome measures in the evaluation of medical products for regulatory approvalL B Burke, D L Kennedy, P H Miskala, et al.
Pharmacotherapy|July 1, 1997
Symptomatic cardiotoxicity associated with 5-fluorouracilC C Meyer, K A Calis, L B Burke, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practiceP S Jensen, V S Bhatara, B Vitiello, et al.
American Journal of Hospital Pharmacy|April 1, 1978
Low cost, manual drug use review of Medicaid recipients to screen prescriber and pharmacist performanceD E Knapp, D L Crosby, L B Burke, et al.
Radiologia|January 23, 2013
A comparison of a T1 weighted 3D gradient-echo sequence with three different parallel imaging reduction factors, breath hold and free breathing, using a 32 channel coil at 1.5 T. A preliminary studyV Herédia, B Dale, R Op de Campos, et al.
Pageof 1